SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capital One Financial Corp. is a financial holding company, which engages in the provision of financial products and services. It operates through the following segments: Credit Card, Consumer Banking, and Commercial Banking. The Credit Card segment includes domestic consumer and small business card lending, and international card lending businesses. The Consumer Banking segment consists of branch-based lending and deposit gathering activities for consumers and small businesses. The Commercial Banking segment includes lending, deposit gathering and treasury management services to commercial real estate and commercial and industrial customers. The company was founded by Richard D. Fairbank on July 21, 1994 and is headquartered in McLean, VA.

Capital One Financial Corp.

Capital One is trending following the final approval of its Discover Financial acquisition, a deal many believe will reshape the credit card market and enhance its competitive stance. However, community conversation is also heavily focused on broader sector headwinds, including proposed credit card interest rate caps and lingering concerns about consumer credit quality.

Alchemy Pay

Alchemy Pay (ACH) is trending due to a rapid succession of new partnerships and expanded fiat on-ramp integrations, notably with Ripple's RLUSD stablecoin, alongside securing its 10th U.S. Money Transmitter License. Community discussion is highly polarized, with many anticipating a significant "altcoin season" rally driven by increasing utility and regulatory compliance, while others express frustration, calling it a "pump and dump" that struggles to hold gains.

Polygon

Polygon (POL) is trending due to surging network usage and significant token burning, which are driving substantial on-chain revenue growth and creating token scarcity. The community widely views POL as highly undervalued, with strong bullish sentiment centered on its long-term potential as a leading scaling solution for payments and its institutional adoption.

Reactive Network is the first parallelized interoperability execution layer, utilising a new form of smart contract we call reactive smart contracts.   Reactive smart contracts are able to react to on-chain events autonomously and execute their own user defined logic to initiate new transactions. This allows a virtually limitless number of use cases to achieve fully decentralized on-chain automation.

Reactive Network

Reactive Network (REACT) is trending due to its pivotal role as the first project integrated into Ethereum's new EIL testnet, which aims to unify L2s and enable advanced on-chain automation and cross-chain triggers. The community is exceptionally bullish, anticipating substantial growth as arbitrage from its former token concludes and new integrations highlight its critical utility for decentralized finance. Investors are actively accumulating, believing its limited supply and expanding ecosystem position it as a foundational infrastructure for the unified Ethereum.

The White Whale

WHITEWHALE CRYPTO is generating significant buzz and trending as community members actively debate its future, citing strong volume and a recent exchange listing as key catalysts. While some speculate it's a 'pump and dump,' many are highlighting its locked liquidity and comparing its rapid ascent to other successful meme coins like FARTCOIN, advocating for a 'HODL' strategy amidst the volatility.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is generating significant buzz due to its Alpha DaRT technology, which has shown strong disease control and immune-preserving properties in pancreatic cancer studies. The community is actively discussing multiple upcoming catalysts, including major healthcare conference presentations, anticipated regulatory approvals in Japan and the US, and notable institutional buying as the company's market cap surpasses a key milestone. This momentum positions DRTS as a leading innovator in the rapidly expanding biotech and radiopharma sectors, with strong bullish sentiment around its transformative cancer treatments.

DBX ETF Trust - Xtrackers Harvest CSI 300 China A-Shares ETF

Xtrackers Harvest CSI 300 China A-Shares ETF

ASHR is experiencing significant momentum due to renewed optimism for China's economic recovery, underpinned by Goldman Sachs' upgraded forecasts and a perceived de-escalation in US-China trade tensions. The community is actively discussing substantial options activity and the potential for a broader bull market, as China's central bank continues monetary easing to stabilize capital markets and boost domestic confidence.

Exchange Traded Concepts Trust - ROBO Global Robotics and Automation Index ETF

Exchange Traded Concepts Trust - ETCT ROBO Global Robotics and Automation Index ETF

ROBO is trending as investors anticipate a "golden age" for robotics and automation, with numerous discussions highlighting breakthroughs in humanoid and single-use robots poised to address labor gaps and inefficiency. Community sentiment is overwhelmingly bullish, viewing this ETF as a strong vehicle to capture the physical AI revolution and benefit from significant industry investment. Broader technological advancements and upcoming industry events are further fueling excitement around the sector's foundational progress.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is trending amid recent presidential proposals regarding credit card interest rate caps, which sparked broad discussion, but many in the community emphasized that Visa's revenue is primarily from transaction fees, not interest, seeing any dip as a buying opportunity. This perspective is reinforced by the company's strong earnings report, showcasing robust payment and cross-border volume growth, alongside strategic initiatives in stablecoin settlements and AI-driven commerce.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is trending amidst widespread community discussion following a political proposal to cap credit card interest rates, sparking debate over its potential market impact. While some investors anticipate a significant pullback, others are highlighting that the company's core revenue stems from transaction processing fees, not interest rates charged by card-issuing banks. This distinction is driving active discussion on whether the proposal truly impacts Mastercard's fundamentals or simply presents a buying opportunity for those looking beyond immediate volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations

AMRN jumps 17% after Q4 and FY2025 preliminary sales beat expectations. The release also reflected positive Q4 cash flow and progress on cost cuts.

Bayer Accelerates Growth With siRNA, AI Deals and Pipeline Progress

Bayer AG enters into collaborations to develop a heart-targeted siRNA therapy and AI technology, expanding its push into next-gen genetic medicines. 

Halper Sadeh LLC Encourages THS, FOLD, REVG Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages THS, FOLD, REVG Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages THS, FOLD, REVG Shareholders to Contact the Firm to Discuss Their...

GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug

Monte Rosa shares surge 45% after interim phase I data show that MRT-8102 drives deep NEK7 degradation and reduces sharp inflammation markers.

KRYS Stock Surges 57% in a Year: More Upside Potential in 2026?

Shares of Krystal Biotech soar 57% in a year as strong Vyjuvek uptake and steady pipeline progress continue to push the stock higher.

EXEL Collaborates With Natera for Late-Stage Colorectal Cancer Study

Exelixis teamed with Natera on the phase III STELLAR-316 study testing zanzalintinib in resected stage II/III colorectal cancer. Stock gains. 



OTLK Stock Crashes 67% in a Week: Here's What You Need to Know

Outlook Therapeutics stock plunges 67% in a week after the FDA issues a third CRL rejecting its ONS-5010 BLA for wet AMD, again seeking confirmatory data.

Celcuity Stock Up 677% in 6 Months: What's Behind This Huge Increase?

CELC shares surge as NDA filing and strong phase III data boost optimism around gedatolisib's potential.

Will Galafold Be Able to Aid FOLD's Top Line Heading Into Q4 Earnings?

Galafold drives over 80% of Amicus product revenues, with $371.5M in the first nine months of 2025 sales as investors await Q4 sales performance.

Halper Sadeh LLC Encourages DBRG, FOLD, DVAX Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages DBRG, FOLD, DVAX Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages DBRG, FOLD, DVAX Shareholders to Contact the Firm to Discuss Their...

Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

Amicus Therapeutics Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

FOLD
Amicus Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest FOLD News

FOLDAmicus Therapeutics Inc